Male MS Patients'Safety, Tolerability and Efficacy Outcomes Do Not Differfrom Female Patients Treated with Diroximel Fumarate: EVOLVEMS-1 Ad-hoc Analysis

Authors
Category Primary study
JournalNeurology
Year 2023
This article has no abstract
Epistemonikos ID: 96c9047835a56681d5999880a17c48117f40cafe
First added on: Nov 03, 2023